Injectable Unit Raising Funds In Ankleshwar
Email
Phone
Google
LinkedIn
Facebook
Product / Service
They are into manufacturing of leuprolide depot injection, octreotide injection, Tenecteplase acetate injection, liposomal amphotericin B, Propofol, Morphine, Fentanyl, Pethidine, Tramadol, Diazepam, and about 150 more.
Clientele type
They export majority of their products to countries like Malawi, Comoros, Mozambique, Rwanda, Angola, Cameroon, Venezuela, Papua New Guinea, Oman, Bhutan, Lebanon, Myanmar, Kyrgyzstan, Swaziland, and UAE.
Premises
OWNED
Premise Size: 3500 Sq Mtr
Market Value (in INR): 7.00 Cr
Plant Approvals: Uganda, Ethiopia, Kenya, DR Congo, Ghana, Nigeria, Peru, Philippines, Sri Lanka, Uzbekistan, and Yemen. Upcoming Audits: Libya, Iraq, Hungary (Application No.-51431/2023), Botswana, Thailand, and Nepal. Exporting to direct/ merchant: Malawi, Comoros, Mozambique, Rwanda, Angola, Cameroon, Venezuela, Papua New Guinea, Oman, Bhutan, Lebanon, Myanmar, Kyrgyzstan, Swaziland, and UAE. Products under registration: Pakistan, Magnolia (product registered waiting for PO), Dominican Republic, Guatemala, Honduras, Kazakhstan, Nicaragua, Panama, Vietnam, Azerbaijan, Ecuador, El Salvador, Gabon, Cambodia, and Georgia. Under Discussion: Russia, Bahrain, and Jordan.
Asking Price Includes
The terms of the transaction will be discussed with potential investors.
Asking Price
INR 10.00 Cr
Minimum ticket size
INR 10.00 Cr
Reason
They are seeking a Strategic Investor who can help them grow their business.
Other Details
Their turnover is predominantly derived from their Ampoule line, accounting for 98% of current revenues. With the vial line now operational, they anticipate a revenue increase exceeding 100% in the next fiscal year, as evidenced by their pre-booked orders with advances received. Their product development is focused on niche molecules, including leuprolide depot injection, octreotide injection, Tenecteplase acetate injection, liposomal amphotericin B, Propofol, and a range of nanoparticle-based formulations currently in their pipeline. They have space to put one Lyo and one PFS line now working on the Biosimilar filling line (28D). Also studying bulk biosimilar production both mammalian and microbial.
Keywords
Business Tags
₹10 to ₹200 Cr
Complete Investment Banking Solution in 120 Days
Seamless Fundraising/M&A transactions
Start your growth journey with our 25+ Years of Experienced Professional Team.
Contact IBGrid TeamFrequently Asked Questions
How to contact a business owner directly to buy or invest in a business?
Connecting with a business owner directly is simple! Just follow these 3 easy steps: 1. Create your FREE Investor/Buyer profile on IndiaBizForSale 2. Explore the 'Business Opportunities' section to find 10,000+ business opportunities matching your investment preferences. 3. Click on the 'Contact Business' button and connect with business owner directly. Check here to know how it worksNote: Once you create your profile, you will get ONE introduction credit, allowing you to contact any ONE featured business.
How does IndiaBiz verify the business information?
The business opportunity is either posted by the business owner or advisor. After that, our team checks the information for completeness, language, and accuracy. Once the basic checks are met; only then the opportunity is published. We also get users' feedback for the opportunities they contact and based on their feedback, the opportunity maybe put on HOLD till further clarification. Many opportunities are not published when it does not pass through our internal procedure checks. We sincerely request you to carry out complete due diligence before taking the transaction ahead. In addition, the contact details of the business are verified via phone/email.
What to consider before buying or investing in a business?
Below are some of the factors that need to be considered before buying or investing in a business:- Growth prospects of the industry and business
- Sales, profitability, and cash flow of the business should be considered
- Consideration you have to pay; form of consideration (either cash or shares or some combination of both) to be paid?
- Source of financing the purchase
- Amount of additional investment that will be required to grow business
- Does the business have second-line of management?
- Are you going to run the business on day-to-day basis or appoint some professional for the same?
- What decisions are to be taken to improve the profitability of the business?
- Time period of payback or return is envisaged from the business?
- Any long-term strategic benefit or synergy with your existing business?
- Will the clients continue with the business after the acquisition?
